EQS-Adhoc: Fresenius Medical Care AG : Fresenius Medical Care AG resolves share buyback program with a total volume of EUR 1 billion in tranches within 2 years
|
EQS-Ad-hoc: Fresenius Medical Care AG / Key word(s): Share Buyback Bad Homburg, June 17, 2025 – Fresenius Medical Care AG (“Company”) has decided to conduct a share buyback program with a volume of EUR 1 billion (excluding ancillary costs) in tranches within two years after the start of the program. The execution of the share buyback program in tranches is planned to commence in the second half of 2025. The shares shall be acquired on the stock exchange and are to be predominantly redeemed and, to a significantly lesser extent, may be used for allocations under incentive-based compensation plans. The share buyback program is based on the authorization to purchase and use treasury shares granted by the Company’s Annual General Meeting on May 20, 2021. Continuation of the share buyback program beyond the current authorization is subject to the necessary resolutions of the Company’s bodies.
End of Inside Information
17-Jun-2025 CET/CEST The EQS Distribution Services include Regulatory Announcements, Financial/Corporate News and Press Releases. |
| Language: | English |
| Company: | Fresenius Medical Care AG |
| Else-Kröner-Straße 1 | |
| 61352 Bad Homburg | |
| Germany | |
| Phone: | +49 (0) 6172- 609 2525 |
| Fax: | +49 (0) 6172- 609 2301 |
| E-mail: | ir@freseniusmedicalcare.com |
| Internet: | www.freseniusmedicalcare.com |
| ISIN: | DE0005785802 |
| WKN: | 578580 |
| Indices: | DAX |
| Listed: | Regulated Market in Frankfurt (Prime Standard); Regulated Unofficial Market in Berlin, Dusseldorf, Hamburg, Hanover, Munich, Stuttgart, Tradegate Exchange; NYSE, Luxembourg Stock Exchange |
| EQS News ID: | 2156174 |
| End of Announcement | EQS News Service |
|
|
2156174 17-Jun-2025 CET/CEST
Boersengefluester.de (BGFL) provides an overview of the key figures on sales, earnings, cash flow and dividends to help you better assess the fundamental development of the respective companies. All information is entered manually in our database - the source is the respective annual reports. All estimates for future figures are provided by BGFL.
| The most important financial data at a glance | ||||||||
| 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025e | ||
| Sales1 | 17.476,56 | 17.859,06 | 17.618,69 | 19.398,02 | 19.453,62 | 19.335,91 | 20.012,00 | |
| EBITDA1,2 | 3.862,72 | 4.090,31 | 3.475,97 | 3.350,00 | 3.121,41 | 3.134,65 | 3.445,00 | |
| EBITDA-Margin3 | 22,10 | 22,90 | 19,73 | 17,27 | 16,05 | 16,21 | 17,22 | |
| EBIT1,4 | 2.269,56 | 2.304,41 | 1.852,29 | 1.511,76 | 1.369,44 | 1.392,39 | 1.700,00 | |
| EBIT-Margin5 | 12,99 | 12,90 | 10,51 | 7,79 | 7,04 | 7,20 | 8,50 | |
| Net Profit (Loss)1 | 1.438,50 | 1.435,83 | 1.219,03 | 894,33 | 732,46 | 740,87 | 935,00 | |
| Net-Margin6 | 8,23 | 8,04 | 6,92 | 4,61 | 3,77 | 3,83 | 4,67 | |
| Cashflow1,7 | 2.566,95 | 4.233,16 | 2.489,50 | 2.167,38 | 2.628,80 | 2.386,14 | 2.650,00 | |
| Earnings per share8 | 3,96 | 3,96 | 3,31 | 2,30 | 1,70 | 1,83 | 2,50 | |
| Dividend per share8 | 1,20 | 1,34 | 1,35 | 1,12 | 1,19 | 1,44 | 1,50 | |
1 in Mio. Euro; 2 EBITDA = Earnings before interest, taxes, depreciation and amortisation; 3 EBITDA in relation to sales; 4 EBIT = Earnings before interest and taxes; 5 EBIT in relation to sales; 6 Net profit (-loss) in relation to sales; 7 Cashflow from operations; 8 in Euro; Source: boersengefluester.de
Auditor: PricewaterhouseCoopers
All relevant valuation ratios, dates and other investor information on your share at a glance. Good to know: All data comes from boersengefluester.de and is updated daily. This means you are always up to date. You can get brief explanations of the key figures by moving the cursor or mouse over the relevant field.
| INVESTOR-INFORMATION | ||||||
| ©boersengefluester.de | ||||||
| Fresenius Medical Care | ||||||
| WKN | ISIN | Legal Type | Marketcap | IPO | Recommendation | Plus Code |
| 578580 | DE0005785802 | AG | 11.765,88 Mio € | 02.10.1996 | Kaufen | 9F2C6J8F+2R |
| PE 2026e | PE 10Y-Ø | BGFL-Ratio | Shiller-PE | PB | PCF | KUV |
| 13,59 | 17,76 | 0,77 | 11,77 | 0,83 | 4,93 | 0,61 |
|
Dividend '2023 in € |
Dividend '2024 in € |
Dividend '2025e in € |
Div.-Yield '2025e in % |
| 1,19 | 1,44 | 1,50 | 3,75% |
| Annual General Meeting | Q1-figures | Q2-figures | Q3-figures | Annual press conference |
| 21.05.2026 | 05.05.2026 | 04.08.2026 | 04.11.2025 | 13.03.2025 |
| Distance 60-days-line | Distance 200-days-line | Performance YtD | Performance 52 weeks | IPO |
| -8,23% | -11,30% | -9,33% | -12,40% | +83,50% |
Founded in 2013 by Gereon Kruse, the financial portal boersengefluester.de is all about German shares - with a clear focus on second-line stocks. In addition to traditional editorial articles, the site stands out in particular thanks to a large number of self-developed analysis tools. All tools are based on a completely self-maintained database for more than 650 shares. As a result, boersengefluester.de produces Germany's largest profit and dividend forecast.
Contact
